Distalmotion has secured a strategic investment from Johnson & Johnson Innovation to bolster expansion of its DEXTER robotic surgery system into ambulatory surgery centers (ASCs), the company announced Monday. The move underscores growing interest in deploying robotic technologies outside of traditional hospital settings. For the Lausanne, Switzerland-based medical technology company, the backing adds to its momentum following a $150 million Series G financing round in 2025, which … [Read more...]
Distalmotion Raises $150M, Increases Focus on ASCs
Global medtech company Distalmotion has successfully closed its Series G funding round after raising $150 million. The new funding will be used to increase adoption of the Dexter robotic surgery system and to support ongoing clinical and product development efforts. Dexter has been incorporated into clinical practice across Europe and the U.S., with nearly 3,000 patients treated. “Investors see strong momentum behind the shift of soft-tissue surgery to outpatient settings, along with a … [Read more...]
The Rise of Surgical Robotics in ASCs: Breaking Barriers to Adoption
The robot doctor is in. While surgical robotics have traditionally been the domain of large and well-resourced hospital systems, there is a growing movement bringing robotics into ambulatory surgery centers (ASCs). As technology evolves, surgical robotics are set to become a staple in outpatient care, offering new opportunities for ASC operators. Yet there are barriers to overcome, including cost constraints and patient-safety concerns. “Robotics in ASCs is a challenge because of the … [Read more...]